Protalix BioTherapeutics (PLX) Enterprise Value (2010 - 2026)
Protalix BioTherapeutics' quarterly Enterprise Value came in at -$10.8 million in Q1 2026, up 68.93% year-on-year from -$6.4 million in Q1 2025, and up 33.76% quarter-over-quarter from -$16.3 million in Q4 2025.
Protalix BioTherapeutics has reported Enterprise Value for 17 years, with the latest figure at -$10.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 68.93% year-over-year to -$10.8 million; the trailing twelve-month figure through Mar 2026 stood at -$10.8 million (up 68.93% YoY), and the FY2025 full-year result was -$16.3 million, down 8.13% from the prior year.
- Enterprise Value for Q1 2026 stood at -$10.8 million, up from -$16.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$10.8 million in Q1 2026, with the low at -$48.5 million in Q1 2024.
- Average Enterprise Value over 5 years is -$31.3 million, with a median of -$32.9 million recorded in 2022.
- Year-over-year, Enterprise Value slumped 100.9% in 2023 and soared 68.93% in 2026.
- Tracing PLX's Enterprise Value over 5 years: stood at -$22.2 million in 2022, then plunged by 100.9% to -$44.6 million in 2023, then soared by 66.18% to -$15.1 million in 2024, then slipped by 8.13% to -$16.3 million in 2025, then surged by 33.76% to -$10.8 million in 2026.
- The last three Enterprise Value figures came in at -$10.8 million (Q1 2026), -$16.3 million (Q4 2025), and -$29.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.79 Mn |
| Dec 31, 2025 | -16.30 Mn |
| Sep 30, 2025 | -29.37 Mn |
| Jun 30, 2025 | -33.40 Mn |
| Mar 31, 2025 | -34.74 Mn |
| Dec 31, 2024 | -15.07 Mn |
| Sep 30, 2024 | -27.41 Mn |
| Jun 30, 2024 | -45.03 Mn |
| Mar 31, 2024 | -48.49 Mn |
| Dec 31, 2023 | -44.56 Mn |
| Sep 30, 2023 | -40.98 Mn |
| Jun 30, 2023 | -48.18 Mn |
| Mar 31, 2023 | -33.04 Mn |
| Dec 31, 2022 | -22.18 Mn |
| Sep 30, 2022 | -20.81 Mn |
| Jun 30, 2022 | -28.57 Mn |
| Mar 31, 2022 | -32.92 Mn |
| Dec 31, 2021 | -38.99 Mn |
| Sep 30, 2021 | -48.66 Mn |
| Jun 30, 2021 | -76.94 Mn |
| Mar 31, 2021 | -70.43 Mn |
| Dec 31, 2020 | -20.72 Mn |
| Sep 30, 2020 | -41.29 Mn |
| Jun 30, 2020 | -34.99 Mn |
| Mar 31, 2020 | -36.68 Mn |
| Dec 31, 2019 | -17.79 Mn |
| Sep 30, 2019 | -21.44 Mn |
| Jun 30, 2019 | -25.10 Mn |
| Mar 31, 2019 | -30.36 Mn |
| Dec 31, 2018 | -37.81 Mn |
| Sep 30, 2018 | -41.87 Mn |
| Jun 30, 2018 | -28.33 Mn |
| Mar 31, 2018 | -41.32 Mn |
| Dec 31, 2017 | -51.16 Mn |
| Sep 30, 2017 | -33.48 Mn |
| Jun 30, 2017 | -34.53 Mn |
| Mar 31, 2017 | -48.02 Mn |
| Dec 31, 2016 | -63.28 Mn |
| Sep 30, 2016 | -51.32 Mn |
| Jun 30, 2016 | -54.63 Mn |
| Mar 31, 2016 | -66.67 Mn |
| Dec 31, 2015 | -76.37 Mn |
| Sep 30, 2015 | -34.25 Mn |
| Jun 30, 2015 | -43.24 Mn |
| Mar 31, 2015 | -47.96 Mn |
| Dec 31, 2014 | -54.77 Mn |
| Mar 31, 2014 | -77.69 Mn |
| Dec 31, 2013 | -86.40 Mn |
| Sep 30, 2013 | -91.40 Mn |
| Jun 30, 2013 | -33.13 Mn |
| Mar 31, 2013 | -41.87 Mn |
| Dec 31, 2012 | -52.04 Mn |
| Sep 30, 2012 | -50.22 Mn |
| Jun 30, 2012 | -59.28 Mn |
| Mar 31, 2012 | -45.61 Mn |
| Dec 31, 2011 | -27.00 Mn |
| Sep 30, 2011 | -34.56 Mn |
| Jun 30, 2011 | -44.05 Mn |
| Mar 31, 2011 | -50.23 Mn |
| Dec 31, 2010 | -35.90 Mn |
| Sep 30, 2010 | -44.40 Mn |
| Jun 30, 2010 | -54.96 Mn |